Log in to save to my catalogue

Tumor Suppressor MicroRNAs in Clinical and Preclinical Trials for Neurological Disorders

Tumor Suppressor MicroRNAs in Clinical and Preclinical Trials for Neurological Disorders

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a05142608f294d5d87af96128e6a6813

Tumor Suppressor MicroRNAs in Clinical and Preclinical Trials for Neurological Disorders

About this item

Full title

Tumor Suppressor MicroRNAs in Clinical and Preclinical Trials for Neurological Disorders

Publisher

Switzerland: MDPI AG

Journal title

Pharmaceuticals (Basel, Switzerland), 2024-03, Vol.17 (4), p.426

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Cancers and neurological disorders are two major types of diseases in humans. We developed the concept called the “Aberrant Cell Cycle Disease (ACCD)” due to the accumulating evidence that shows that two different diseases share the common mechanism of aberrant cell cycle re-entry. The aberrant cell cycle re-entry is manifested as kinase/oncoprotei...

Alternative Titles

Full title

Tumor Suppressor MicroRNAs in Clinical and Preclinical Trials for Neurological Disorders

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a05142608f294d5d87af96128e6a6813

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a05142608f294d5d87af96128e6a6813

Other Identifiers

ISSN

1424-8247

E-ISSN

1424-8247

DOI

10.3390/ph17040426

How to access this item